Oxtex and Brainomix have secured cash from the $2m fund set up earlier this year.
Oxford University’s Isis Fund, worth a total of £1.25m ($2m), has made its first investments from the fund. Both medical device spin-out Oxtex and medical software developer Brainomix both received investment.
The Isis Fund was set up in February 2014 by Isis Innovation and Parkwalk Advisors.
The fund participated in Brainomix’s £1.2m ($1.95m) funding round, led by Mark Jaffray of Chimera Partners and also including Parkwalk Advisors. Brainomix, which took part in the Isis Software Incubator, is working on software…
